As of 2025-07-07, the Relative Valuation of Polydex Pharmaceuticals Ltd (POLXF) is 0.50 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.99 USD, the upside of Polydex Pharmaceuticals Ltd based on Relative Valuation is -74.8%.
The range of the Relative Valuation is (0.01) - 1.60 USD.
| Range | Selected | |
| Trailing P/E multiples | 0.3x - 1.0x | 0.6x |
| Forward P/E multiples | 8.0x - 28.0x | 18.0x |
| Fair Price | (0.01) - 1.60 | 0.50 |
| Upside | -100.5% - -19.3% | -74.8% |
| Date | P/E |